Literature DB >> 19091033

Towards a research agenda for global malaria elimination.

Marcel Hommel.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19091033      PMCID: PMC2604876          DOI: 10.1186/1475-2875-7-S1-S1

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


× No keyword cloud information.

For the past twenty years, many scientific papers on malaria have begun with statements such as 'there are an estimated three billion people at risk of the disease'; or '300–600 million episodes of clinical falciparum malaria occur each year, killing between one and three million individuals annually'; or 'the global burden of malaria exceeds 40 million disability-adjusted life years' [1,2]. These figures may once have been a credible approximation, but need to be looked at today with considerable scepticism, even when they appear in official statements. Indeed, figures of malaria incidence/prevalence or of disease burden, are mostly based on reports of 'presumptive diagnosis', the accuracy of which is 50% at best and less than 5% in situations of low endemicity. Figures relating to malaria mortality are even less reliable, because the exact cause of death is always difficult to determine, even in hospital settings [3]. Recent studies of severe malaria in children in Malawi and in Kenya suggest that, in at least 25% of cases, the WHO definition of severe malaria is unable to exclude concomitant bacterial or viral infections, which may actually be responsible for the fatal outcome [4]. The field reality is worse, when one considers that many malaria cases occur in remote areas, where the resources for making adequate diagnosis are not available. However, a general pattern is emerging, based on recent publications and public statements and despite this inadequacy of the baseline figures, that malaria incidence is decreasing worldwide and, in some cases, this has actually been documented by reliable data. For example, child mortality on the Kenyan coast has been reduced [5], and, over the past few years, there has been a fall of 50–75% in malaria incidence in Zanzibar [6], Eritrea [7], Ethiopia and Rwanda [8]. Interestingly, there have been reports from travel clinics in Europe indicating a reduction in their imported malaria cases [9,10]. Policy-makers are keen to believe that this reduction of malaria cases and of malaria mortality is the result of their activity and the mass interventions that have been made possible through unprecedented funding for malaria control. An estimated US$1.5 billion was spent in 2007, 47% of which was disbursed by international donor agencies, including the Global Fund [11]. Existing control measures, including large-scale distribution of insecticide-impregnated bed nets, improved diagnosis using rapid tests, treatment using a combination of effective drugs including artemisinin, and prevention/treatment of high-risk target groups such as pregnant women, are known to work and will undoubtedly have had an impact when implemented on an operational scale in some endemic areas. However, a decrease of malaria incidence has not always followed implementation of control measures and other factors, both human and climatic, may have also played a part. Nevertheless, the decreasing pattern of incidence is encouraging and, by giving funding agencies a first impression of success, it has helped enormously in the advocacy for further increases in the global funding effort, which are considered necessary to achieve malaria control. As a result, Bill and Melinda Gates surprised the malaria community in October 2007 by expressing their firm commitment to global 'malaria eradication' [12]. This was a bold statement, since the word 'eradication' had not been used in official statements since the early 1970s, when the failure of an earlier global eradication attempt was recognized. The statement has had three noticeable effects: (i) almost immediately, other agencies, hitherto committed to control, jumped on the eradication band wagon, (ii) it put the goal of 'elimination', if not yet of 'eradication', on the global agenda with a notional target date of 2025, and (iii) the notion of elimination by 2025 captured the imagination of the scientific community working on malaria, which moved in a short space of time from a realistic awareness of the enormity of the complex and seemingly insoluble problem of malaria control to cautious optimism that elimination by 2025 is a real possibility – the Emperor's New Clothes, perhaps? Nobody believes that elimination will be easy to achieve and it will undoubtedly require sustained, high level funding and political commitment for many years. Indeed, history shows that the single most important cause of failure of the 1960s eradication campaign was the rapid loss of political commitment once control had been shown to work. The move from control to elimination is actually a quantum leap. If it were once possible to state that all the tools for control were available and that no further research was required, it is doubtful whether elimination could be achieved with those same tools. There is now a need to define a new research agenda and to identify the differences between control and elimination. Malaria Journal is now in its seventh year of existence and it has become a major journal in the discipline, reporting on all aspects of malaria, 'from the bench, to the bedside and to the bush'. There will no doubt be many papers published on malaria elimination in the future, but it is fitting that Malaria Journal should be the first journal to publish a series of review articles looking at the many aspects of the research agenda for malaria elimination on a global scale.

Competing interests

The author declares that they have no competing interests.
  11 in total

1.  The billion-dollar malaria moment.

Authors:  Mark Grabowsky
Journal:  Nature       Date:  2008-02-28       Impact factor: 49.962

Review 2.  When is "malaria" malaria? The different burdens of malaria infection, malaria disease, and malaria-like illnesses.

Authors:  K A Koram; M E Molyneux
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

3.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

4.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

5.  Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment.

Authors:  Mac Otten; Maru Aregawi; Wilson Were; Corine Karema; Ambachew Medin; Worku Bekele; Daddi Jima; Khoti Gausi; Ryuichi Komatsu; Eline Korenromp; Daniel Low-Beer; Mark Grabowsky
Journal:  Malar J       Date:  2009-01-14       Impact factor: 2.979

6.  Defining childhood severe falciparum malaria for intervention studies.

Authors:  Philip Bejon; James A Berkley; Tabitha Mwangi; Edna Ogada; Isaiah Mwangi; Kathryn Maitland; Thomas Williams; J Anthony G Scott; Mike English; Brett S Lowe; Norbert Peshu; Charles R J C Newton; Kevin Marsh
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

7.  Declining incidence of malaria imported into the UK from West Africa.

Authors:  Ron H Behrens; Bernadette Carroll; Valerie Smith; Neal Alexander
Journal:  Malar J       Date:  2008-11-10       Impact factor: 2.979

8.  The decline in paediatric malaria admissions on the coast of Kenya.

Authors:  Emelda A Okiro; Simon I Hay; Priscilla W Gikandi; Shahnaaz K Sharif; Abdisalan M Noor; Norbert Peshu; Kevin Marsh; Robert W Snow
Journal:  Malar J       Date:  2007-11-15       Impact factor: 2.979

9.  The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?

Authors:  Ron H Behrens; Bernadette Carroll; Jiri Beran; Olivier Bouchaud; Urban Hellgren; Christoph Hatz; Tomas Jelinek; Fabrice Legros; Nikolai Mühlberger; Bjørn Myrvang; Heli Siikamäki; Leo Visser
Journal:  Malar J       Date:  2007-08-23       Impact factor: 2.979

10.  Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar.

Authors:  Achuyt Bhattarai; Abdullah S Ali; S Patrick Kachur; Andreas Mårtensson; Ali K Abbas; Rashid Khatib; Abdul-Wahiyd Al-Mafazy; Mahdi Ramsan; Guida Rotllant; Jan F Gerstenmaier; Fabrizio Molteni; Salim Abdulla; Scott M Montgomery; Akira Kaneko; Anders Björkman
Journal:  PLoS Med       Date:  2007-11-06       Impact factor: 11.069

View more
  21 in total

1.  Malaria elimination in Malawi: research needs in highly endemic, poverty-stricken contexts.

Authors:  Mark L Wilson; Edward D Walker; Themba Mzilahowa; Don P Mathanga; Terrie E Taylor
Journal:  Acta Trop       Date:  2011-11-15       Impact factor: 3.112

2.  Nuclear magnetic resonance: a tool for malaria diagnosis?

Authors:  Stephan Karl; Lucía Gutiérrez; Michael J House; Timothy M E Davis; Tim G St Pierre
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

3.  Genome wide linkage study, using a 250K SNP map, of Plasmodium falciparum infection and mild malaria attack in a Senegalese population.

Authors:  Jacqueline Milet; Gregory Nuel; Laurence Watier; David Courtin; Yousri Slaoui; Paul Senghor; Florence Migot-Nabias; Oumar Gaye; André Garcia
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

4.  Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

Authors:  Bernhards Ogutu; Alfred B Tiono; Michael Makanga; Zulfiqarali Premji; Adama Dodji Gbadoé; David Ubben; Anne Claire Marrast; Oumar Gaye
Journal:  Malar J       Date:  2010-01-22       Impact factor: 2.979

5.  Malaria elimination in iran, importance and challenges.

Authors:  Mohsen Rezaei Hemami; Ali Akbari Sari; Ahmad Raeisi; Hassan Vatandoost; Reza Majdzadeh
Journal:  Int J Prev Med       Date:  2013-01

6.  A sub-microscopic gametocyte reservoir can sustain malaria transmission.

Authors:  Stephan Karl; David Gurarie; Peter A Zimmerman; Charles H King; Tim G St Pierre; Timothy M E Davis
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

7.  The role of simple mathematical models in malaria elimination strategy design.

Authors:  Lisa J White; Richard J Maude; Wirichada Pongtavornpinyo; Sompob Saralamba; Ricardo Aguas; Thierry Van Effelterre; Nicholas P J Day; Nicholas J White
Journal:  Malar J       Date:  2009-09-14       Impact factor: 2.979

8.  Malaria paediatric hospitalization between 1999 and 2008 across Kenya.

Authors:  Emelda A Okiro; Victor A Alegana; Abdisalan M Noor; Juliette J Mutheu; Elizabeth Juma; Robert W Snow
Journal:  BMC Med       Date:  2009-12-09       Impact factor: 8.775

9.  Spatial and temporal distribution of falciparum malaria in China.

Authors:  Hualiang Lin; Liang Lu; Linwei Tian; Shuisen Zhou; Haixia Wu; Yan Bi; Suzanne C Ho; Qiyong Liu
Journal:  Malar J       Date:  2009-06-12       Impact factor: 2.979

10.  Discourse on malaria elimination: where do forcibly displaced persons fit in these discussions?

Authors:  Holly A Williams; Heiko Hering; Paul Spiegel
Journal:  Malar J       Date:  2013-04-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.